Back to mobile site

Monsanto (MON) and ToolGen Report Global Licensing Agreement on CRISPR Platform

August 16, 2017 8:33 AM EDT Send to a Friend
Monsanto Company (NYSE: MON) and ToolGen, Inc., announced today that the companies have reached a global licensing agreement for the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login